Hims & Hers Health, Inc. stock is up 36.27% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
07 Nov 14:36 | 19 Jan, 2024 | 6.00 | 873 | ||
15 Nov 14:50 | 16 Jan, 2026 | 4.00 | 21 | ||
15 Nov 16:01 | 17 Jan, 2025 | 10.00 | 12219 | ||
15 Nov 19:58 | 19 Jan, 2024 | 5.00 | 3638 | ||
17 Nov 20:42 | 17 Nov, 2023 | 8.00 | 601 | ||
20 Nov 17:12 | 17 Jan, 2025 | 10.00 | 11824 | ||
20 Nov 18:44 | 17 Jan, 2025 | 10.00 | 11824 | ||
22 Nov 14:40 | 17 Jan, 2025 | 7.00 | 1899 | ||
22 Nov 16:07 | 19 Jan, 2024 | 6.00 | 767 | ||
27 Nov 14:30 | 16 Jan, 2026 | 12.00 | 657 |
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category. In addition, it offers medical consultation services and health and wellness products through wholesale partners.